Yosuke Kitagawa

9PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical infection agents (incl. prions)Medical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 27, 2026
Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.

|Mar 30, 2026
Effects of short- and long-term mutant IDH1 inhibition on radiosensitivity across genetically diverse patient-derived IDH1-mutant glioma cells.

Yosuke Kitagawa, Logan D Muzyka, Ami Kobayashi

|Jul 11, 2025
Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy.

Miyu Kikuchi, Hirokazu Takami, Yukari Kobayashi

|Jul 11, 2024
Mutant IDH1 inhibition induces dsDNA sensing to activate tumor immunity.

Meng-Ju Wu, Hiroshi Kondo, Ashwin V Kammula

|May 08, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition.

Ali M Nasser, Lisa Melamed, Ethan A Wetzel

|Mar 13, 2024
Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma.

Ami Kobayashi, Yosuke Kitagawa, Ali Nasser

Pageof 2

Frequent Collaborators

4 joint publications

Hiroaki Wakimoto

3 joint publications

Daniel P Cahill

3 joint publications

Ami Kobayashi

2 joint publications

Takahide Nejo